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Double  strand  DNA  breaks  (DSBs)  are  one  of  the  most  challenging  forms  of  DNA  damage  which,  if  left
unrepaired,  can  trigger  cellular  death  and  can  contribute  to cancer.  A  number  of studies  have  been focused
on  DNA-damage  response  (DDR)  mechanisms,  and  most  of  them  rely  on  the  induction  of DSBs  triggered
by  chemical  compounds  or radiations.  However,  genotoxic  drugs  and  radiation  treatments  of  cultured
cell  lines  induce  random  DSBs  throughout  the  genome,  thus  heterogeneously  across  the cell population,eywords:
ite-speciﬁc DSBs
siSI restriction enzyme
pb1-CTD
-TEFb
leading  to variability  of  the  cellular  response.  To overcome  this  aspect,  we  used here  a  recently  described
cell-based  DSBs  system  whereby,  upon  induction  of  an  inducible  restriction  enzyme,  hundreds  of site-
speciﬁc  DSBs  are  generated  across  the  genome.  We  show  here  that sequence-speciﬁc  DSBs  are  sufﬁcient
to  activate  the  positive  transcription  elongation  factor  b (P-TEFb),  to trigger  hyperphosphorylation  of
the  largest  RNA  polymerase  II carboxyl-terminal-domain  (Rpb1-CTD)  and  to induce  activation  of  p53-
transcriptional  axis  resulting  in  cell  cycle  arrest.. Introduction
DNA damage represents an impressive challenge to the integrity
f genetic material and cells have evolved multifaceted mech-
nisms collectively termed the DNA damage response (DDR) to
etect, sign and properly respond to various DNA injuries. DDR
nduces a global transcription reprogramming called transcrip-
ional stress response (TSR) with the majority of genes being
epressed. A subset of genes are activated in TSR, among them
hose whose activity is required to halt the cell cycle and repair
he damage or eventually carry the cells toward apoptosis [1–5].
A common feature of cellular response to DNA damage induced
y UV light, X-ray irradiation or different genotoxic drugs is
yperphosphorylation of CTD of the largest Rpb1 subunit of RNA
olymerase II (Rpb1-CTD) [6,7]. Rpb1-CTD represents the docking
ite for a number of factors that, by interacting with and inducing
ts phosphorylation/dephosphorylation at Ser/Thr residues, regu-Please cite this article in press as: G. Napolitano, et al., Sequence-speciﬁc d
phorylation, Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2013), http://dx.d
ate its activity as well as transcription progression along the gene
nit and associated co-transcriptional events [8,9]. P-TEFb is one
f the kinases that are involved in the regulation of RNA poly-
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ttp://dx.doi.org/10.1016/j.mrfmmm.2013.07.005© 2013 Elsevier B.V. All rights reserved.
merase II (RNAPII) activity by phosphorylating the Rpb1-CTD tail
during the transcriptional cycle. P-TEFb activity is regulated by
a dynamic equilibrium between the small active complex (SC),
made of CDK9/CyclinT1, and the large inactive complex (LC) where
CDK9/CycT1 are associated to a snRNP complex made of 7SK
snRNA, Hexim1, MeCPE and Larp7 [10–14]. The dynamic equi-
librium between SC and LC P-TEFb complexes can be perturbed
by transcriptional arrest, hypertrophic signals and by a variety of
DNA-damaging agents that induce a rapid release of the P-TEFb
LC complex with a concomitant accumulation of the active P-TEFb
complex [15–21].
A number of studies have been focused on RNAPII transcription
stalling in the presence of UV induced lesions, while the behavior
of RNAPII when encounters a DSB lesion is a relative recent argu-
ment whose ﬁndings are still controversial, as recently discussed
by Pankotai and Soutoglou [22 and references therein]. It has been
suggested that the number and topology of the breaks may  affect
the molecular mechanisms mediating arrest of RNAPII [22–24].
Because the induction of DSBs triggered by chemical compounds
or radiations of cultured cell lines causes random DSBs through-
out the genome, several systems have been developed that rely onouble strand breaks trigger P-TEFb-dependent Rpb1-CTD hyperphos-
oi.org/10.1016/j.mrfmmm.2013.07.005
the use of restriction enzymes capable to generate unambiguously
positioned sequence-speciﬁc DSBs, thus inducing a homoge-
neous, sequence speciﬁc, reproducible DNA damage [25–28].
Here we addressed whether sequence speciﬁc DSBs affect the
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hosphorylation status of RNAPII and the relevant kinase involved
n such effect. To this end we used the U2OS-derived cellular sys-
em (HA-AsiSI-ER, named AsiSI in the text) based on the activation
f the inducible AsiSI restriction enzyme [28]. We  found that site-
peciﬁc DSBs trigger disruption of the P-TEFb LC complex leading
o accumulation of active SC P-TEFb. Moreover, as consequence, we
ound hyperphosphorylation of Rpb1-CTD. In the same experimen-
al conditions we also observed activation of the p53-dependent
ranscriptional pathway and cell cycle arrest.
. Materials and methods
.1. Cell culture and drug treatments
HA-AsiSI-ER-U2OS (AsiSI) and U2OS cells were cultured in Dulbecco’s modi-
ed Eagle’s medium (DMEM) supplemented with 10% fetal calf serum and 1 mg/ml
uromycin at 37 ◦C in humidiﬁed atmosphere with 5% CO2. Induction of HA-AsiSI-
R chimera was carried out as described in Iacovoni et al. [28] using 4-OHT (300 nM,
rom Sigma Aldrich). Doxorubicin (1 M),  camptothecin (12 M)  and nutlin-3
10 M)  are from Sigma Aldrich. Flavopiridol (50 nM)  was  obtained from NIH AIDS
esearch and Reference Reagent Program (Cat. #9925).
.2. RNA interference
The following small interference RNA reagents (siRNAs) were purchased from
harmacon: On Target Plus SMART pool targeting CDK9 (L-003243), On Target Plus
on-target pool (D-001830-20).
AsiSI cells transfected with 100 nM siRNA targeting CDK9 or with scramble,
on-targeting siRNA pool using MicroPorator Digital Bio Technology, a pipette-type
lectroporation system (Seoul, Korea). siRNAs were introduced into each 3 × 106 dis-
ociated cells in 100 l volume according to manufacturer’s instructions (1230 V, 10
idth, 4 pulses) and seeded in 100 mm culture dishes as previously reported [29].
fter 48 h, cells were treated for 8 h with 4-OHT or vehicle (NT). After the treatments,
ells were collected and extracts prepared as described in next paragraph.
.3. Glycerol gradient, co-immunoprecipitation and immunoblotting
Whole-cell extracts were obtained using buffer A [11]. For glycerol gradient, pro-
ein extracts were ultracentrifuged at 40,000 rpm for 16 h at 4 ◦C in SW40.1 rotor
n a pre-formed 5–45% discontinuous glycerol gradient containing buffer A. Sam-
les were collected in 10 fractions (1 ml  each starting from the top), and 20 l of
ach fraction were separated by SDS-PAGE and analyzed by western blotting using
ppropriate antibodies.
Co-immunoprecipitation analyses were performed using whole-cell extracts
1 mg)  incubated with the anti-Cyclin T1 (sc-10750) antibody. After extensive
ashes the recovered beads were resuspended in Laemmli buffer, resolved on SDS-
AGE and analyzed by western blotting.
The following antibodies were used: mouse monoclonal anti-8WG16 (MMS
26R) and mouse monoclonal anti-H5 (MMS 129R) from Covance, Inc.; rabbit
olyclonal anti-Cdk9 (sc 8338), goat polyclonal anti-Cyclin T1 (sc-8127), mouse
onoclonal anti-p53 (sc-126), rabbit polyclonal anti-p21 (sc-397), mouse mono-
lonal anti-actinin (sc-17829), mouse monoclonal anti-Cyclin B1 (sc-215) and rabbit
olyclonal anti-Cyclin T1 (sc-10750) from Santa Cruz Biotechnology, Inc., Santa Cruz,
A; mouse monoclonal anti-P-p53 Ser15 (9286) from Cell Signaling Technology,
nc.; the rabbit polyclonal anti-Hexim1 (C4) was already described [30]. Binding was
isualized by enhanced chemiluminescence (ECL-plus Kit, Amersham Biosciences).
.4. Immunoﬂuorescence and co-localization assays
Cells at the density of 5 × 104 were grown on coverslips in 2.5 cm dishes.
mmunoﬂuorescence was  carried out as previously described [31]. Brieﬂy, for
mmunoﬂuorescence, U2OS cells were ﬁxed and stained with rabbit anti-H2AX
Cell Signaling Technology Inc.) for 30′ at 37 ◦C after brief permeabilization (0,1%
riton X-100/PBS) and pre-blocking (2% BSA-3% NRS) steps. After extensive washes,
nti-rabbit-Cy3 secondary antibody has been used at the dilution of 1:400 for 30′
t room temperature. For co-localization analyses, after ﬁxation and pre-blocking
2%BSA–3%NS), AsiSI cells were stained with both rabbit anti-H2AX and mouse
nti-HA (Invitrogen Corporation) for 30 min  at 37 ◦C. Anti-mouse-Cy3 and anti-
abbit-FITC (Jackson Immunotech, West Grove, PA) secondary antibodies have been
sed after washes to detect mouse anti-HA and rabbit anti-H2AX respectively.
uclei were stained with DAPI (Invitrogen Corporation). Images were acquired
sing a Nikon Eclipse TE 2000-U microscope and digitally processed using Adobe
hotoshop CS4 software.Please cite this article in press as: G. Napolitano, et al., Sequence-speciﬁc d
phorylation, Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2013), http://dx.d
.5. qRT-PCR
cDNA was  prepared from total RNA (1 mg)  with Quantitec Reverse Transcrip-
ion Kit (Qiagen) according to manufacturer’s protocol. cDNA of each sample was PRESS
search xxx (2013) xxx– xxx
prepared in triplicate and normalized to the expression of the housekeeping beta-
glucoronidase (GUS) as previously described [18,19]. Quantitative analyses were
performed using SYBR GREEN 2X PCR Master Mix  (Applied Biosystems). Reac-
tions were run in the AbiPrism 7900 HT sequence detector system (Perkin-Elmer
Applied Biosystems). All values represent the average of at least three indepen-
dent experiments. DNA  sequences of the oligos used in this work are available upon
request.
2.6. FACS analyses
For monoparametric DNA proﬁle cells were treated as indicated in the text,
collected by centrifugation and washed in phosphate-buffered saline (PBS). Cells
were resuspended in hypotonic solution 0.1%Na-Citrate, 50 g/ml propidium iodide,
50  g/ml RNAse, and 0.00125% Nonidet P40, incubated in absence of light for 30′ at
room temperature and diluted at the ﬁnal concentration of 1 × 105 cells/ml.
Biparametric BrdU/DNA analysis: cells were treated as already described [32].
Brieﬂy, after a 20 min  pulse with 10 M 5-bromo-2-deoxyuridine (BrdU, from Sigma
Aldrich), culture medium was changed and cells were treated as indicated in the text.
After treatments, cells were ﬁxed with ice-cold ethanol, washed with PBS/1% BSA
and  subjected to a denaturation step with 2 N HCl for 25 min  at room temperature.
Denaturation was  stopped with 0.1 M Na2B4O7. After washes with PBS/1% BSA, cells
were incubated with anti-BrdU (cat. No. 347580, Becton Dickinson) in PBS/1% BSA.
After incubation with the secondary anti-mouse FITC (F2883, Sigma Aldrich) cells
were washed and incubated in absence of light overnight with PI (2.5 g/ml) and
RNAse (50 g/ml). Cytoﬂuorimetric acquisitions and analyses were performed on
a  Becton Dickinson FACScalibur ﬂow cytometer using FACSDiva, CellQuest Pro and
ModFit LT 3.0 softwares.
3. Results and discussion
3.1. AsiSI induced DSBs trigger P-TEFb-dependent Rpb1-CTD
hyperphosphorylation
A common feature of the cellular response to UV radiations and
drug-induced DNA damage is the induction of a high phosphoryla-
tion degree of the Rpb1-CTD [6,7,33]. The CTD tail of Rpb1 serves
as a scaffold for the interaction of a wide range of factors that
orchestrate transcription and co-transcriptional processes, and it
has been suggested that the hyper-phosphorylated status of the
CTD represents a signal for rapid Rpb1 proteasomal degradation
[34–36].
However, in-depth understanding of the functional conse-
quences of hyper-phosphorylation triggered by diverse DNA
damaging agents has been hampered because most DNA damag-
ing agents act non-selectively throughout the genome, generating
a heterogeneous genotoxic response. Here we used an inducible
restriction enzyme cellular system whereby hundreds of DSBs are
generated across the genome. AsiSI cells express the 8 bp restric-
tion enzyme AsiSI fused to HA epitope and to a modiﬁed estrogen
receptor ligand binding domain that induces nuclear localization
of the enzyme only after 4-OHT administration to cells [28].
As shown in Fig. 1A, we  observed nuclear accumulation of HA-
AsiSI-ER chimera by immunoﬂuorescence analysis of AsiSI cells
treated with 4-OHT for increasing time, and we detected appear-
ance of -H2AX foci after 0.5 h following drug administration.
Then we  tested CTD-Rpb1 phosphorylation status following
DSBs generation. Western blots analyses showed that CTD hyper-
phosphorylation takes place after 2 h of 4-OHT treatments (Fig. 1B).
Using 8WG16 antibody that recognizes the unphosphorylated
heptapeptides of the CTD thus detecting total Rpb1 (that is, all iso-
forms), we  observed accumulation of the slower IIo band (mostly
hyper-phosphorylated) and a concomitant decrease of the faster
hypo-phosphorylated IIa form of Rpb1. The hyper-phosphorylation
of Rpb1-CTD increased during time of treatment as documented
by the ratio between the hyper-phosphorylated IIo and hypo-ouble strand breaks trigger P-TEFb-dependent Rpb1-CTD hyperphos-
oi.org/10.1016/j.mrfmmm.2013.07.005
phosphorylated IIa forms of CTD. We  included in our experiments
treatment with Camptothecin (CPT) that is known to induce DSBs
[37]. CTD hyper-phosphorylation was also assayed using the anti-
H5 antibody that mainly recognizes the phospho-Ser2-CTD.
Please cite this article in press as: G. Napolitano, et al., Sequence-speciﬁc double strand breaks trigger P-TEFb-dependent Rpb1-CTD hyperphos-
phorylation, Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2013), http://dx.doi.org/10.1016/j.mrfmmm.2013.07.005
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Fig. 1. DBSs determine hyper-phosphorylation of Rpb1 carboxyl-terminal domain that is dependent on P-TEFb activity. (A) AsiSI cells were treated with 4-OHT or vehicle
(NT)  for the indicated time. Fixed cells were stained with anti-HA and anti-H2AX antibodies to evaluate nuclear accumulation of the HA-AsiSI-ER chimera and the presence
of  DSBs respectively by immunoﬂuorescence assay. DAPI staining of nuclei is shown. (B) AsiSI cells were treated with 4-OHT for the indicated time, with camptothecin
(CPT)  for three hours or with vehicle (NT) as indicated. Cellular extracts were prepared and probed with anti-8WG16 and anti-H5 antibodies. Histogram bars show the ratio
between IIo and IIa forms of Rpb1-CTD. Standard deviation bars are shown. (C) Upper panel: U2OS cells were treated with 4-OHT or vehicle (NT) for the indicated time. Total
cellular extracts were prepared and stained with anti-8WG16. Lower panel: U2OS cells were treated as in (C) upper panel. After ﬁxation cells were stained with anti-H2AX.
Nuclei were stained with DAPI. (D) AsiSI cells were treated with vehicle (NT), 4-OHT alone or in combination with the P-TEFb inhibitor FP as indicated. Cellular extracts were
probed  with anti-8WG16 antibody. The ratio between Rpb1-IIo and Rpb1-IIa is shown in the upper histogram panel together with standard deviation bars. (E) AsiSI cells
were  treated as in (D). Extracts were probed with anti-H5 antibody that recognizes the P-Ser2 of CTD heptads in Rpb1. Values shown in histograms are the average of 2–3
different biological experiments, and the values have been calculated as fold changes to the untreated sample (set to one). (F) AsiSI cells were transfected with siRNA for
CDK9  or with scramble siRNA as indicated. After 48 h, cells were treated with 4-OHT (or vehicle, NT) for 8 h and collected. Extracts were prepared and RNAPII probed by WB
with  anti-8WG16 and anti-H5 antibodies. WB anti-CDK9 is shown to evaluate CDK9 silencing. Blots anti-actinin are shown as loading control.
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Fig. 2. AsiSI-dependent DBSs induce P-TEFb activation. (A) AsiSI cells were treated
with 4-OHT or vehicle (NT) as indicated. Whole cell extract were prepared and
separated on a discontinuous glycerol gradient (5–45%) by ultracentrifugation.
Fractions were loaded on gel compared with input (i) and immunoblotted with
anti-Hexim1 and anti-CDK9 to evaluate the extent of P-TEFb SC accumulation fol-
lowing DSBs. Immunoblots show that DSBs induced by AsiSI-dependent DNA cuts
induce dissociation of P-TEFb large complex (LC) and the concomitant accumula-
tion of the small complex (SC). (B) AsiSI cells were treated with vehicle (NT), 4-OHT
for the indicated time and with CPT for three hours. 1 mg  of the whole cell extract
was immunoprecipitated with anti-CycT1 (IP:CycT1) or pre-immune serum (IP:no
Ab).  The immunoprecipitated materials were loaded on gel and probed with anti-
CycT1, anti-Hexim1 and anti-CDK9 to evaluate Hexim1 dissociation from P-TEFb.ARTICLEUT-11280; No. of Pages 7
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To exclude that 4-OHT treatment could directly affect Rpb1-CTD
hosphorylation, we treated the parental U2OS cell line with 4-
HT and analyzed Rpb1-CTD phosphorylation as reported in Fig. 1C
upper panel); results showed no direct effect of 4-OHT in U2OS
ells and conﬁrmed that the hyper-phosphorylation of Rpb1-CTD
n AsiSI cells is a consequence of sequence-speciﬁc DSBs. Moreover,
e also assessed that 4-OHT administration to U2OS cells do not
ead to -H2AX foci formation (Fig. 1C, lower panel).
The CTD domain of Rpb1 is a substrate of several kinases in vitro
nd in vivo. Notably, P-TEFb is the kinase responsible of Ser2 phos-
horylation at the switch of transcription from initiation/pausing
o processive elongation. We  sought to determine whether P-TEFb
ight be the kinase responsible for the observed CTD hyper-
hosphorylation following AsiSI-dependent DNA cuts and to this
nd we treated cells with 4-OHT alone or in combination with
avopiridol (FP). FP is considered a potent inhibitor of CDKs with
igniﬁcant selectivity for CDK9 as its IC50 has been found to be
bout 7 times lower than that of the closest CDK IC50 reported
o date [38–40]. As shown in Fig. 1 panel D, the ratio between IIo
nd IIa Rpb1 forms sharply decreases following co-treatments of
ells with 4-OHT and FP. These results were conﬁrmed by probing
he extracts with anti-H5 antibody that recognizes the P-Ser2-CTD
Fig. 1E). Albeit FP shows a high selectivity for CDK9, we  cannot
xclude that the observed effects could be also due to a concomi-
ant FP inhibition of other cellular kinases. To further validate the
ole of CDK9 in the hyper-phosphorylation of Rpb1-CTD-(Ser2) fol-
owing DSBs, we  silenced CDK9 expression by using speciﬁc siRNAs.
siSI were transfected with siRNAs targeting CDK9, as well as with
cramble, non-targeting siRNAs for 48 h before treatment with 4-
HT. As shown in Fig. 1F, in cells silenced for CDK9 expression,
-OHT-dependent CTD hyper-phosphorylation was impaired.
Collectively, these data showed that AsiSI-induced DSBs trigger
yper-phosphorylation of Rpb1-CTD at Ser2 and that P-TEFb is the
inase responsible for the most of the observed Rpb1-CTD-(Ser2)
hosphorylation.
.2. AsiSI-induced DSBs determine dissociation of the P-TEFb
omplex
It is known that initiation of transcriptional response following
enotoxic stress induced by several DNA damaging agents causes
 rapid release of P-TEFb from the inactive LC complex concurrent
ith Rpb1-CTD hyper-phosphorylation [17–19,33–36].
To investigate if AsiSI-dependent DNA damage determines P-
EFb dissociation, we analyzed the ratio between SC and LC
orms of P-TEFb after treatment of cells with 4-OHT for differ-
nt times by glycerol fractionation of cell lysates. Cellular lysates
rom AsiSI cells were ultracentrifuged on a glycerol gradient and
he recovered fractions were analyzed by western blotting with
nti-CDK9 and anti-HEXIM1 antibodies. As shown in Fig. 2A, treat-
ent with 4-OHT shortly (1.5 h) determined dissociation of P-TEFb
compare NT and 4-OHT 1.5 h lanes 7–8, Fig. 2A) that remained
onstant until 4 h of treatment (4-OHT 4 h lanes 7–8, Fig. 2A).
ince the dissociation is not complete, probably reﬂecting the
lighter DNA damaging insult caused by AsiSI DSBs, we wished
o further validate P-TEFb dissociation by co-immunoprecipitation
nalyses. Cyclin T1 associated proteins were immunoprecipitated
n untreated, 4-OHT and control camptothecin (CPT) treated cells
o investigate the presence of the CDK9 and Hexim1 proteins in
he complex. As shown in Fig. 2B, dissociation of Hexim1 fromPlease cite this article in press as: G. Napolitano, et al., Sequence-speciﬁc d
phorylation, Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2013), http://dx.d
he LC P-TEFb started at 2 h after treatment and increased at
 h of 4-OHT treatment, to levels comparable to those obtained
ollowing CPT treatment. Collectively, these data demonstrated
hat sequence-speciﬁc DNA damage induced by AsiSI determinesImmunoblots show that 4-OHT determines Hexim1 dissociation from P-TEFb at the
same extent of CPT treatment.
P-TEFb activation, which in turn is responsible for CTD-Ser2 hyper-
phosphorylation (Figs. 1 and 2).
3.3. AsiSI-induced DSBs determine activation of the p53
transcriptional axis with a concomitant G2/M cell cycle arrest
DNA damage alters the global pattern of gene expression that
orchestrates a variety of cellular mechanisms including DNA  repair,
growth arrest and/or apoptosis. Following DNA damage, p53 is
phosphorylated and thus activated by ATM and ATR kinases, as well
as by their substrates Chk1 and Chk2 [1,2]. The activated and sta-
ble p53 enhances the expression of several genes that cooperate
to arrest cell cycle, as for example CDKN1A (p21) and GADD45a as
well as to induce proapoptotic markers such as BBC3 (PUMA) and
BAX.
Firstly, we determined whether AsiSI directed DNA breaks were
sufﬁcient to induce p53 and p21 gene expression. As shown in Fig. 3
(panel A), 4-OHT led to p53 accumulation, even though at lesser
extent than drugs capable to induce genotoxicity and cellular stress
(doxorubicin DXR, CPT, FP) or Nutlin-3, which disrupting p53-ouble strand breaks trigger P-TEFb-dependent Rpb1-CTD hyperphos-
oi.org/10.1016/j.mrfmmm.2013.07.005
MDM2  interaction, releases the active form of p53 in the absence
of DNA damage. According to these results, we also observed a
concomitant increase of the p21 protein levels.
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Fig. 3. AsiSI-induced DSBs determine activation of p53 target genes. (A) Whole cell
extracts from AsiSI cells treated for three hours with vehicle (NT), doxorubicin (DXR),
camptothecin (CPT), ﬂavopiridol (FP), nutlin-3 (nutl) and with 4-OHT for the indi-
cated time were prepared and probed with anti-p53 and anti-p21. p53 and p21
proteins accumulate in response to diverse DNA damaging agents or stress cell
drugs. Actinin has been probed as a loading control. (B) AsiSI cells were treated
with  vehicle (NT), 4-OHT as indicated and CPT for three hours. Total mRNA was pre-
pared and levels of BBC3, GADD45a, CDKN1A, BAX, CDK1 and Cyclin B1 mRNAs were
quantiﬁed by qRT-PCR and normalized to GUS mRNA level. Standard deviation bars
are indicated. (C) Whole cell extracts from AsiSI cells treated with vehicle (NT), CPT
and 4-OHT for the indicated time were prepared, separated on gel and probed with
a
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[nti-P-p53-Ser15 and anti-Cyclin B1. Actinin has been probed as a loading control.
mmunoblots show that phosphorylation of p53(Ser15) takes place following 4-OHT
nd  CPT treatments.
Assuming by these ﬁndings the activation of the p53-dependent
ranscriptional pathway, we analyzed the expression levels of ded-
cated p53 gene targets as CDKN1A, BBC3, GADD45a and BAX by
RT-PCR. Our data show that site-speciﬁc DSBs induced by the
siSI activity caused up-regulation of the p53-dependent analyzed
enes (Fig. 3B). Accordingly, CPT treatments also led to accumu-
ation of CDKN1A and BAX, while BBC3 resulted unaffected and
ADD45a downregulated. GADD45a down-regulation in presence
f p53 over-expression is in agreement to published data [41].
egarding BBC3, we speculate that the differences in BBC3 mRNA
evels after treatments with CTP and 4-OHT are likely dependent
n the speciﬁc cellular system used: it is reported that in the U2OS
arental cell line, BBC3 overexpression following cisplatin admin-
stration is missing because of high presence of miR221-222 that
irectly targets BBC3 mRNA [42,43].Please cite this article in press as: G. Napolitano, et al., Sequence-speciﬁc d
phorylation, Mutat. Res.: Fundam. Mol. Mech. Mutagen. (2013), http://dx.d
Since it is known that following UV-dependent DNA damage,
yclin B1 and its kinase partner CDK1 are down-regulated due to
eduction of GCN5 association to their respective promoter regions
44,45], we also looked at their expression. As shown in Fig. 3B, PRESS
search xxx (2013) xxx– xxx 5
we observed reduction of Cyclin B1 and CDK1 expression following
4-OHT treatment.
We also analyzed p53-(Ser15) phosphorylation status and
Cyclin B1 protein levels by comparing the effect of AsiSI-dependent
DSBs to CPT treatment. As shown in Fig. 3C we observed increas-
ing amount of phosphorylated p53 following 4-OHT treatment and
CPT, and a relative small reduction of Cyclin B1 protein levels at
24 h after 4-OHT treatment.
To monitor cell cycle distribution upon induction of DSBs
induced by AsiSI site-speciﬁc cuts, we performed monoparametric
FACS analyses of propidium-stained cells upon drug administra-
tion and compared the results to those obtained by treatment with
CPT. As shown in Fig. 4A, while cells treated with CPT arrested in
G1, with cells in G1 phase increasing from 36% to 50% after drug
administration, on sharp contrast, AsiSI-dependent DSBs deter-
mined G2/M arrest, with G2/M cells increasing from 16% to 46%
following 4-OHT treatment. Our data are in agreement with pre-
vious report by the Legube group [46]; besides, we show that cell
cycle arrest at G2/M is already evident after 8 h of treatment with
4-OHT.
We also performed a bromodeoxyuridine/DNA (BrdU/DNA)
biparametric ﬂow cytometric analysis to obtain a distinct eval-
uation of cell cycle perturbations of cells that are in S phase
(BrdU-positive cells) or in G1 or in G2/M (BrdU-negative cells) after
AsiSI-induced DNA breaks [32].
Fig. 4B shows the biparametric BrdU/DNA analysis on the
AsiSI cells following 4-OHT treatments for different times. As
shown, G2/M arrest was evident after 8 h of treatment (compare
4-OHT 8 h to growing t = 8 h). Moreover, after 24 h of treatment
the majority of cells were blocked in G2/M (compare 4-OHT
24 h to growing t = 24); among these cells a population of cells
that was in G1 started a new DNA synthesis cycle although
remaining halted in G2/M (BrdU positive cells). In fact, G2/M BrdU-
positive cells increased from 6% to 30%, thus conﬁrming the results
obtained with monoparametric DNA proﬁle analysis (Fig. 4A and
B).
Data presented here showed that DSBs induced by AsiSI activity
determine down-regulation of Cyclin B1/CDK1 and the concomi-
tant block of cell cycle in G2/M. The activated Cyclin B1/CDK1
complex exerts its role in promoting cells mitosis. In the pres-
ence of DSBs, it has been shown that p21 binds Cyclin B1/CDK1
to block its activity by nuclear retention [47,48]. We  speculate
that the inhibition of Cyclin B1/CDK1 induced by AsiSI activity
mimics the p21-mediated inhibition of the complex, thus halting
cells in G2/M. However, further experiments could address this
point.
Collectively, our results indicate that, in the inducible cellular
system AsiSI the limited amount of breaks induced by the AsiSI
enzyme is sufﬁcient for the repartitioning of P-TEFb in the active SC;
moreover, we suggest that the active CDK9 is responsible for induc-
tion of hyperphosphorylation of Rpb1-CTD in this system. We  found
that site-speciﬁc DSBs trigger the activation of genes that take part
in TSR, namely p53, CDKN1A (p21), BBC3 (PUMA), GADD45a and
BAX similarly to classical non site-speciﬁc inducers of DSBs. In con-
trast to the G1 arrest that follows CPT-mediated damage, in this
cellular model we observed arrest in G2/M as consequence of AsiSI-
induced DSBs.
Although we  cannot exclude a variability of AsiSI enzyme efﬁ-
ciency among cells due to chromatin structure and accessibility,
which could lead to a minor level of heterogeneity in the pro-
duced DNA cuts [28], our data establish that the use of an inducible
enzyme-based DNA damage cellular system may provide a use-ouble strand breaks trigger P-TEFb-dependent Rpb1-CTD hyperphos-
oi.org/10.1016/j.mrfmmm.2013.07.005
ful experimental system not only for an in-depth understanding
of chromatin dynamic involved in DSBs recognition, signaling and
repair, but also in the genetic transcriptional reprogramming that
follows DNA damage.
Please cite this article in press as: G. Napolitano, et al., Sequence-speciﬁc double strand breaks trigger P-TEFb-dependent Rpb1-CTD hyperphos-
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Fig. 4. Site-speciﬁc DSBs induced by AsiSI lead to G2/M arrest. (A) AsiSI cells were treated with vehicle (growing), 4-OHT or CPT as indicated. Cells were prepared and
stained with propidium iodide to analyze their DNA proﬁle by FACS analysis. Data have been reported in histogram graphs. Histograms of DNA proﬁles of analyzed cells
are  also shown. Data are from at least three independent assays. Images are from representative experiments. 4-OHT administration halts cells in G2/M while CPT induces
an  arrest in G1/S phase of cell cycle. (B) Biparametric BrdU/DNA analysis of cells treated with vehicle (growing, upper panels) compared to cells treated with 4-OHT for the
indicated times (4-OHT 8 h and 24 h, lower panels). Cells were ﬁrstly subjected to 20 min  BrdU pulse and then treated as indicated. After ﬁxation, cells were stained with
both  propidium iodide and anti-BrdU and were successively analyzed by ﬂow cytometry. BrdU positive cells marked the DNA replicating fraction at the time of treatments,
thus  allowing us to monitor the effects of the genotoxic insult in relation to cell cycle phase. As time goes on, both BrdU positive and negative cells progressed through
the  cell cycle and the calculated fractions were reported in each dotplot. In particular, G1 BrdU fraction represent cells initially in S phase entering a new cell cycle: part of
these  cells initially completed a ﬁrst round of cell division (G1 BrdU at 8 h) to be stopped in G2/M after an additional DNA replication phase. Images are from representative
experiments. Sequence-speciﬁc DSBs arising from AsiSI activity lead to accumulation of cells in G2/M.
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